2017
DOI: 10.1111/febs.14090
|View full text |Cite
|
Sign up to set email alerts
|

Metabolic reprogramming and epithelial‐to‐mesenchymal transition in cancer

Abstract: Several lines of evidence indicate that during transformation epithelial cancer cells can acquire mesenchymal features via a process called epithelialto-mesenchymal transition (EMT). This process endows cancer cells with increased invasive and migratory capacity, enabling tumour dissemination and metastasis. EMT is associated with a complex metabolic reprogramming, orchestrated by EMT transcription factors, which support the energy requirements of increased motility and growth in harsh environmental conditions… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

16
207
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 248 publications
(227 citation statements)
references
References 100 publications
16
207
0
Order By: Relevance
“…39 EMT is also associated closely with metabolic reprogramming via its transcription factors and supports the energy requirement for increased motility and growth in the tumor microenvironment. 40 Consistent with previous results, our research also indicated an increase in E-cadherin and inhibition of Twist and Vimentin upon FRK absence, in parallel with damage to stemness and induction of metabolic reprogramming. Given such results, we reasoned that the interaction of the metabolic reprogramming and EMT maintained the stemness in lung cancer, which causes resistance to conventional treatment.…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…39 EMT is also associated closely with metabolic reprogramming via its transcription factors and supports the energy requirement for increased motility and growth in the tumor microenvironment. 40 Consistent with previous results, our research also indicated an increase in E-cadherin and inhibition of Twist and Vimentin upon FRK absence, in parallel with damage to stemness and induction of metabolic reprogramming. Given such results, we reasoned that the interaction of the metabolic reprogramming and EMT maintained the stemness in lung cancer, which causes resistance to conventional treatment.…”
Section: Discussionsupporting
confidence: 92%
“…Tumor cells can acquire CSC‐like properties through the EMT process, which is mediated by important transcription factors including Snail 1/2, Twist 1/2, E‐cadherin and Vimentin . EMT is also associated closely with metabolic reprogramming via its transcription factors and supports the energy requirement for increased motility and growth in the tumor microenvironment . Consistent with previous results, our research also indicated an increase in E‐cadherin and inhibition of Twist and Vimentin upon FRK absence, in parallel with damage to stemness and induction of metabolic reprogramming.…”
Section: Discussionsupporting
confidence: 90%
“…In line with the above mentioned findings, our results also demonstrate that during colonization of the brain these features seem even more important than migration and invasion. It is well accepted that, besides migration and invasion, EMT is associated with a complex metabolic reprogramming and chemotherapy resistance . Unfortunately, the previous observations failed to distinguish between the impact of EMT‐induced migration and invasion and the impact of the EMT‐associated metabolic reprogramming.…”
Section: Discussionsupporting
confidence: 69%
“…In the initiation of metastasis, an early step of invasion is largely mediated by the reversible epithelial‐to‐mesenchymal transition (EMT) process, which is associated with the increased resistance to conventional clinical therapies . The EMT process is largely regulated by several transcription factors such as those of the TWIST, the SNAIL, and the ZEB family . Although the exact mechanisms are not well understood, the process of EMT regulation seems to be involved in the cell adhesion and migration during cancer progression, with opportunities for metastasis control.…”
Section: Introductionmentioning
confidence: 99%